An autologous stem cell transplant uses your own stem cells to rebuild your blood and immune system after a round of intensive chemotherapy. The basic idea: doctors collect stem cells from your blood, freeze them, deliver powerful chemotherapy to destroy cancer cells, then return your stem cells so your body can recover. The whole process spans several weeks and involves distinct phases, each with its own purpose.
This type of transplant is most commonly used to treat multiple myeloma, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and other plasma cell disorders. Because the cells come from your own body, there’s no risk of graft-versus-host disease, a serious complication that can happen when donor cells attack the recipient’s tissues.
Mobilization: Moving Stem Cells Into Your Blood
Stem cells normally live deep inside your bone marrow. Before they can be collected, they need to be coaxed out into your bloodstream, a process called mobilization. You’ll receive daily injections of a growth factor that signals your bone marrow to produce large numbers of stem cells and release them into circulating blood. The growth factor works by disrupting the chemical signals that anchor stem cells inside the marrow.
For some patients, a second medication is added to boost the release. This drug blocks a specific receptor on stem cells that keeps them tethered in place, essentially unlocking them so they flood into the bloodstream. The combination tends to produce a higher yield, which matters because doctors need a minimum number of cells to ensure a successful transplant. Mobilization typically takes four to five days of injections before collection begins.
Collection: Harvesting Your Stem Cells
Once enough stem cells are circulating, they’re collected through a process called apheresis. A needle is placed in a vein (or a temporary catheter is used), and your blood is drawn out into a machine that separates out the stem cells. The remaining blood components are returned to your body through a second line. Each session takes several hours, and you may need one to three sessions over consecutive days to collect enough cells.
Doctors track the number of a specific type of blood-forming cell in the collected product to make sure the count is high enough. If the yield falls short, additional mobilization drugs or an extra collection day may be needed.
Freezing and Storing the Cells
After collection, your stem cells are mixed with a cryoprotectant solution that prevents ice crystals from damaging them during freezing. The cells are cooled gradually, about one degree Celsius per minute, down to negative 80 degrees, then transferred to liquid nitrogen tanks where they can remain viable for months or even years. When it’s time for your transplant, the frozen cells are thawed rapidly in a warm water bath and reinfused within minutes. This quick thaw protects cell integrity.
Conditioning: High-Dose Chemotherapy
This is the most physically demanding part of the transplant. Conditioning refers to the intensive chemotherapy (and occasionally radiation) given in the days just before your stem cells are returned. The goal is to wipe out as many remaining cancer cells as possible. Because the doses are far higher than what your body could normally tolerate, they also destroy much of your bone marrow, which is why the saved stem cells are essential.
The specific drugs used depend on the disease being treated. For multiple myeloma, a single high-dose chemotherapy agent is the standard. For Hodgkin’s lymphoma, a four-drug combination is most common and carries a lower treatment-related mortality rate compared to other regimens. Non-Hodgkin’s lymphoma patients typically receive a two-drug combination. Conditioning usually lasts one to seven days, ending a day or two before cell reinfusion.
Reinfusion: Transplant Day
Transplant day, often called “Day 0,” is surprisingly anticlimactic compared to everything that came before it. Your thawed stem cells are infused through a central line, similar to a blood transfusion. The process takes about 30 minutes to an hour. The cells travel through your bloodstream and find their way back into your bone marrow, where they begin producing new blood cells. You might notice a garlic-like taste or smell during infusion from the cryoprotectant solution, which is harmless and fades quickly.
Engraftment: Waiting for New Blood Cells
After reinfusion, there’s a waiting period while your transplanted stem cells settle into the bone marrow and start making new white blood cells, red blood cells, and platelets. This process, called engraftment, typically takes 10 to 14 days but can range from day 10 to day 30 depending on the disease and treatment.
During this window, your blood counts drop to dangerously low levels. Your white blood cell count bottoms out first, leaving you extremely vulnerable to infection. Platelet counts also plummet, and you’ll receive platelet transfusions if they fall below 10,000 (normal is 150,000 to 400,000). Most patients stay in the hospital or visit a transplant center daily during this period. Doctors monitor your absolute neutrophil count closely, and once it rises above 500 for several consecutive days, engraftment is considered successful.
Side Effects During Recovery
The weeks surrounding transplant are rough. The high-dose chemotherapy causes side effects that peak during the engraftment waiting period. Mouth and throat sores (mucositis) are one of the most common and painful complications, making eating and drinking difficult. These sores typically resolve within a few weeks. Nausea and vomiting can persist for 7 to 10 days after the last chemotherapy dose, managed with anti-nausea medications throughout.
Fatigue is often profound and lingers well beyond the hospital stay. Diarrhea, hair loss, and loss of appetite are also common. Because your immune system is essentially absent during the engraftment period, infections are a serious risk and the primary reason for close monitoring. Even after engraftment, it takes 6 months to a year for your immune system to function normally again.
Rebuilding Your Immune System
One detail that surprises many patients: the transplant essentially resets your immune memory. Antibodies you built up from childhood vaccinations are largely wiped out by the conditioning chemotherapy. Starting around 6 months after transplant, you’ll go through a revaccination schedule that resembles what you received as a child. This includes vaccines for diphtheria, tetanus, pertussis, hepatitis B, polio, and pneumococcal disease, spaced out over the first two years. Seasonal flu shots can begin as early as 4 months post-transplant. Certain live vaccines, like measles, mumps, and rubella, are considered optional and handled on a case-by-case basis.
Some vaccines are specifically contraindicated after transplant, including the nasal spray flu vaccine, oral polio, and shingles vaccine. Household contacts and caregivers also need to avoid the nasal flu vaccine within two weeks of being around you.
How Well Does It Work?
Outcomes vary significantly by disease type and how well the cancer responded to initial treatment. For multiple myeloma, the most common reason for autologous transplant, real-world data shows roughly 60% of patients remain progression-free at three years, and about 74 to 75% are alive at five years. These numbers held even for patients older than 65, a group once considered too frail for the procedure.
Autologous transplant is not typically considered a cure for myeloma, but it can extend remission substantially. For certain lymphomas, particularly those that relapse after initial chemotherapy but still respond to salvage treatment, autologous transplant offers a genuine chance at long-term disease control. The treatment-related mortality rate has dropped considerably over the past two decades as supportive care has improved, making it a viable option for a wider range of patients than in earlier eras.